Log In
Print
BCIQ
Print
Print this Print this
 

Vimpat, lacosamide

Also known as: formerly harkoseride

  Manage Alerts
Collapse Summary General Information
Company UCB Group
DescriptionAnticonvulsant that selectively enhances slow inactivation of sodium (Na) channels and modulates collapsin response mediator protein-2 (DPYSL2; CRMP-2)
Molecular Target Collapsin response mediator protein-2 (DPYSL2) (CRMP-2)
Mechanism of Action 
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today